| [参考文献] [1] Kamekura R,Kojima T,Takano K,et al.The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis[J].Clin Exp Allergy,2012 Feb,42(2):218-28. [2] Nakae S,Morita H,Ohno T,et al.Role of interleukin-33 in innate-type immune cells in allergy[J].Allergol Int.2013 Mar;62(1):13-20. [3] Rogala B,Glück J.The role of interleukin-33 in rhinitis.Curr Allergy Asthma Rep.2013 Apr;13(2):196-202. [4] Nabe T.Interleukin(IL)-33:new therapeutic target for atopic diseases [J],J Pharmacol Sci.2014;126(2):85-91. [5]PeiC,BarbourM,Fairlie-ClarkeKJ,et al.Emerging role of interleukin-33 in autoimmune diseases[J].Immunology,2014 Jan,141(1):9-17. [6] Guo Z, Wu J, Zhao J,et al.IL-33 promotes airway remodeling and is a marker of asthma disease severity[J].J Asthma.2014 Oct;51(8):863-9. [7] Haenuki Y, Matsushita K, Futatsugi-Yumikura S,et al.A critical role of IL-33 in experimental allergic rhinitis.J Allergy Clin Immunol[J]. 2012 Jul;130(1):184-94.e11. [8] Xu WD, Zhang M, Zhang YJ,IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy.Hum Immunol.2013 Sep;74(9):1057-60. [9] Baba S,Kondo K,Kanaya K,et al.Expression of IL-33 and its receptor ST2 in chronic rhinosinusitis with nasal polyps[J].Laryngoscope,2014 Apr,124(4):E115-22. [10] Zhao Q, Chen G.Role of IL-33 and its receptor in T cell-mediated autoimmune diseases[J].Biomed Res Int.2014;587376. [11] Saluja R, Ketelaar ME.The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders.Mol Immunol.2015 Jan;63(1):80-5. [12] Nakanishi W,Yamaguchi S,Matsuda A,et al.IL-33,but not IL-25,is crucial for the development of house dust mite antigen-induced allergic rhinitis[J].PLoS One,2013 Oct 25,8(10):e78099. [13] Asaka D,Yoshikawa M,Nakayama T,et al.Elevated levels of interleukin-33 in the nasal secretions of patients with allergic rhinitis[J].Int Arch Allergy Immunol,2012,158 Suppl 1:47-50. [14] Dinarello CA.Overview of the interleukin1 family of ligands and receptors.Semin Immunol.2013 Dec 15,25(6):389-93. [15] Martin MU.Special aspects of interleukin-33 and the IL-33 receptor complex[J].Semin Immunol,2013 Dec 15,25(6):449-57. [16] Baumann R,Rabaszowski M,Stenin,et al.Nasal levels of soluble IL-33R ST2 and IL-16 in allergic rhinitis: inverse correlation trends with disease severity[J].Clin Exp Allergy,2013 Oct,3(10):1134-43. [17] Rüger K,Ottenlinger F,Schr?der M,et al.Modulation of IL-33/ST2-TIR and TLR Signalling Pathway by Fingolimod and Analogues in Immune Cells[J].Scand J Immunol,2014 Dec,80(6):398-407. [18] Bartemes KR,Kephart GM.Enhanced innate type 2 immune response in peripheral blood from patients with asthma[J].J Allergy Clin Immunol.2014 Sep,134(3):671-678.e4. [19] Kamekura R, Kojima T, Takano K, et al.The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis[J].Clin Exp Allergy. 2012 Feb;42(2):218-28. [20] Borish L,Steinke JW.Intedeukin-33 in asthma: how big of a role does it play［J］.Curr Allergy Asthma Rep.2011;11(1):7-11． [21] Kim Y.H,Yang T.Y, Park C.S,et al.Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis[J].Allergy 2012;67:183–190. [22] Talabot-Ayer D, Martin P, Seemayer CA ,et al.Immune-mediated experimental arthritis in IL-33 deficient mice[J].Cytokine,2014 Sep,69(1):68-74. [23] Li D,Guabiraba R,Besnard AG,et al.IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages andinnate lymphoid cells in mice[J].J Allergy Clin Immunol,2014 Dec,134(6):1422-1432.e11. |
